| Stage | UFCS | % of rev | BRK-B | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $392M | 100.00% | $102B | 100.00% | BRK-B ×259.98 |
| Gross profit | $391M | 99.84% | $55.9B | 54.87% | UFCS +45.0pp |
| Operating income | $48M | 12.25% | $17.1B | 16.77% | BRK-B +4.5pp |
| Pre-tax income | $45M | 11.44% | $31.8B | 31.25% | BRK-B +19.8pp |
| Net income | $35M | 8.96% | $25.8B | 25.31% | BRK-B +16.4pp |
| Stage | UFCS | BRK-B | Gap · A − B |
|---|---|---|---|
| Revenue | $392M100.00% | $102B100.00% | BRK-B ×259.98 |
| Gross profit | 99.84%$391M | 54.87%$55.9B | UFCS +45.0pp |
| Operating income | 12.25%$48M | 16.77%$17.1B | BRK-B +4.5pp |
| Pre-tax income | 11.44%$45M | 31.25%$31.8B | BRK-B +19.8pp |
| Net income |
| 8.96%$35M |
| 25.31%$25.8B |
| BRK-B +16.4pp |
No disclosed counterparties: BRK-B.
None